Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme? (Q50157070)
Jump to navigation
Jump to search
scientific article published on 2 June 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme? |
scientific article published on 2 June 2007 |
Statements
1 reference
Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme? (English)
1 reference
1 reference
Lu CY
1 reference
Williams KM
1 reference
2 June 2007
1 reference
1 reference
37
1 reference
9
1 reference
601-606
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference